VRTHF - Veritas Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1475
-0.0042 (-2.77%)
At close: 3:35PM EDT
Stock chart is not supported by your current browser
Previous Close0.1517
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume87,370
Market Cap10.623M
Beta-1.11
PE Ratio (TTM)N/A
EPS (TTM)-0.2220
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    3 Carbon Extractions Enters into Collaboration with CannabisWise Accreditation

    3 Carbon will advise them on quality assurance standards for light hydrocarbon-based manufacturing and extraction methods. CannabisWise is an accreditation program established by the BC based National Institute for Cannabis Health and Education (NICHE) earlier this year in response to Canada’s plan to legalize cannabis. 3 Carbon Extractions CEO Phillip Kwong said, “We are excited to be collaborating with this exciting initiative.

  • GlobeNewswire8 days ago

    Veritas Welcomes MOU Between 3 Carbon Extractions and Rubikon Blockchain

    VANCOUVER, British Columbia, Sept. 11, 2018-- Veritas Pharma Inc. is pleased to announce that 3 Carbon Extractions Inc., an industry leader in regulatory compliant cannabis hydrocarbon extraction solutions, ...

  • GlobeNewswire14 days ago

    Veritas Welcomes Exclusive Marketing Agreement Between 3 Carbon Extractions and ExtractionTek Solutions

    VANCOUVER, British Columbia, Sept. 05, 2018-- Veritas Pharma Inc. is pleased to announce that its subsidiary, 3 Carbon Extractions Inc., has completed an exclusive marketing rights relationship with ExtractionTek ...

  • GlobeNewswire14 days ago

    Veritas Appoints Lorne Mark Roseborough CEO of SunVault Energy to the Board of Directors

    Lui Franciosi commented: “We are very pleased to welcome Mr. Roseborough to Veritas’ Board of Directors. Mr. Roseborough brings a wealth of talent and expertise to the Company.  He’s currently the CEO of SunVault Energy Inc. (SVLT) in Kelowna, B.C., which focuses on bringing cost effective energy generation and storage to the solar industry.  He previously held the position as a Start-up Lead Executive for Dow Corning’s $1.2 billion Semiconductor plant in Clarksville, Tennessee.

  • GlobeNewswire23 days ago

    Veritas Completes Share Purchase Agreement with 3 Carbon Extractions Inc.

    Under the terms of the Agreement as previously announced on April 16, 2018, Veritas has invested $300,000 US into 3 Carbon and issued 1,500,000 common shares of Veritas at a deemed price of $0.40 per share to the shareholders of 3 Carbon. The cash consideration will be used to build a scalable extraction facility at a location to be determined by the board of Veritas.

  • GlobeNewswirelast month

    Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited

    VANCOUVER, British Columbia, Aug. 15, 2018-- Veritas Pharma Inc. is pleased to announce that it has signed a Memorandum of Understanding with IsCann Group Limited located in Be'er Tuvya, Israel with the ...

  • GlobeNewswirelast month

    Veritas Signs MOU with the Chamber of Commerce, Industry, Services and Tourism Brazil & Puerto Rico

    VANCOUVER, British Columbia, Aug. 13, 2018-- Veritas Pharma Inc. is pleased to announce that it has entered into a Memorandum of Understanding with the Chamber of Commerce, Industry, Services and Tourism ...

  • GlobeNewswirelast month

    Frankfurt’s Clearstream Banking Lifts Settlement Restrictions on Securities Active in Medical Cannabis

    VANCOUVER, British Columbia, Aug. 08, 2018-- Veritas Pharma Inc. is pleased to announce that Clearstream Banking, a major central securities depository based in Frankfurt, Germany, which announced on June ...

  • GlobeNewswire2 months ago

    Veritas Pharma Announces Loan to Marapharm and Cancellation of Stock Options

    VANCOUVER, British Columbia, July 27, 2018-- Veritas Pharma Inc. is pleased to announce that effective June 25, 2018, it cancelled a total of 3,272,000 incentive stock options granted under the Company’ ...

  • GlobeNewswire2 months ago

    Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund

    Veritas Pharma Inc. (CSE:VRT) (VRTHF) (2VP.F), (“Veritas” or the “Company”) is pleased to announce that it has signed an Intellectual Property Sharing Agreement (“Joint IP”) with Sativa Investments PLC (“Sativa”) (NEX:SATI), UK’s first medicinal cannabis investment fund. Veritas through its subsidiary company, Cannevert Therapeutics Ltd., will apply its pharmacological methods on cannabis strain lead selection to assist Sativa’s application to the UK Home Office Drugs Licensing and Compliance Unit for a medicinal cannabis growing license.

  • GlobeNewswire3 months ago

    Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries

    Veritas Pharma Inc. (CSE:VRT) (VRTHF) (2VP.F) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios Theodorou has been appointed as its business development agent in Cyprus. Currently, medical cannabis is legal in Cyprus, nonetheless doctors may only prescribe it to patients suffering from specific ailments, typically as a last resort and strictly for palliative care.

  • Should You Be Concerned About Veritas Pharma Inc’s (FRA:2VP) Shareholders?
    Simply Wall St.5 months ago

    Should You Be Concerned About Veritas Pharma Inc’s (FRA:2VP) Shareholders?

    In this article, I’m going to take a look at Veritas Pharma Inc’s (DB:2VP) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...

  • PR Newswire7 months ago

    BioCan Technologies Signs Memorandum of Understanding with Veritas Pharma

    CALGARY, Feb. 28, 2018 /CNW/ - BioCan Technologies Inc. ("BioCan" or the "Company") is pleased to announce that it has entered into a Memorandum of Understanding ("MoU") with Veritas Pharma Inc. ("Veritas") (CSE:VRT) (VRTHF) (Frankfurt: 2VP) to collaborate with Veritas on an exclusive basis to undertake further investigations of cannabis strains being developed by the research arm of Veritas, Cannevert Therapeutics Ltd. ("CTL"). The focus will be to optimize the genetics of their cannabis plants for scientific and clinical testing over the next two years.  Pursuant to the MoU, definitive agreements in respect of the transactions contemplated in the MoU are expected to be executed by the parties on or before July 31, 2018. BioCan's CEO, Trevor Peters, stated "We are pleased to be working with Veritas and their scientific teams to develop medically relevant cannabis strains and cannabinoid formulations with optimal therapeutic properties.